Problem

Mederva Health addresses the gap between fragmented health data and actionable preventive care. Patients may have records, lab results, wearable data, and behavioral information spread across different systems, while primary-care visits provide limited time and context; Mederva contrasts this with a typical PCP visit of roughly 15 minutes. The economic pain is also significant: integrated longevity services can represent more than $15,000 of value, while some alternatives charge over $10,000, putting personalized prevention out of reach for many people.

The core use case is turning a vague health concern into a focused intervention. Mederva’s example is a chronically fatigued patient whose labs are worsening and whose medications are accumulating; by connecting her records, identifying root causes, and isolating three high-impact changes, the company aims to replace generic advice with a practical plan that improves energy, risk factors, and long-term health.

Product / Service

Mederva describes itself as an insurance-covered behavioral-health and longevity-care program. It connects a patient’s existing medical records, lab results, wearable data, and behavioral information, analyzes them against longevity research, and identifies the two or three upstream changes most likely to improve the patient’s goals. The patient chooses priorities such as sleeping better, reducing medication, or having more energy, while Mederva builds a personalized protocol rather than offering a generic dashboard or checklist.

The service combines technology with human support. A dedicated coach translates the protocol into daily habits, conducts weekly check-ins, adjusts the plan as the patient improves, and coordinates with the patient’s doctor. Mederva says it generally requires no new blood tests or out-of-pocket costs, verifies insurance eligibility before enrollment, and reports that most patients qualify for full coverage. On the provider side, the company says its AI and coaches help primary-care clinics deliver more continuous, concierge-level care without adding comparable operational work.

Market

Mederva competes in digital health, telehealth, consumer health services, and the emerging healthspan or longevity-care category. Its current positioning is more specific than a general telemedicine service: it is trying to make data-driven lifestyle and behavior change a reimbursed extension of primary care. Function Health is an explicit comparison on Mederva’s site, while third-party market mapping places broader adjacent competitors such as HealthTap, Ro, and One Medical in the competitive set.

The company appears to be an active, early-stage venture rather than a proven scaled operator. Y Combinator lists Mederva as a Winter 2022 company and active, and third-party funding data reports $500,000 raised from Y Combinator in a seed round. Mederva also says it partners with clinics, but the available public sources do not disclose customer counts, revenue, reimbursement volume, or profitability; therefore, its pre-revenue status cannot be confirmed from the evidence, and its clearest public traction signals are its active YC profile, clinic-oriented model, and insurance-based offering.